Organization meeting with prospective investors and strategics to finalize $ten million Series A funding round
DANA POINT, Calif., March 16, 2023 (GLOBE NEWSWIRE) — Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced right now that Jon Greenwald, Chief Executive Officer, will present at the fourth annual Life Science Intelligence (LSI) USA ’23 Emerging Medtech Summit on March 22, 2023, at 11:30 a.m. PT (Track 1) in Dana Point, California.
The presentation will highlight Caira’s mission to make sophisticated orthopedic technologies additional accessible to surgeons, sufferers, ambulatory surgery centers (ASCs) and hospitals worldwide by eliminating the adoption barriers inherent in current technologies with the aim of disrupting the $13 billion joint replacement marketplace with Caira’s superior, proprietary technologies. The organization will also introduce investors and strategics to its initial solution – the Caira Radar Navigation Program for Total Knee Replacement (TKR). TKR is the biggest joint replacement segment by procedural volume, as properly as the segment with the highest price of patient dissatisfaction and the highest revision burden.
The Caira TKA Radar Navigation Program is the initial sub-millimeter correct radar tracking technique for orthopedic surgery and delivers considerable improvements more than the higher-expense, huge-footprint and invasive surgical hardware provided by incumbent surgical navigation and robotic systems. Utilizing sophisticated radar surgical tracking and quick landmark registration, the Caira technique seamlessly integrates into surgeons’ workflow, enhancing accuracy, efficiency and repeatability when simultaneously decreasing expense, complexity and lots of of the dangers related with legacy technologies.
“Orthopedic surgeons will need sophisticated technologies that are aligned with the expense, efficiency and patient outcome wants of the swiftly increasing worldwide joint replacement marketplace,” stated Caira Co-Founder Morteza Meftah, M.D., Associate Professor of Orthopaedic Surgery at NYU Langone Health-related Center and President of the International Society for Technologies in Arthroplasty. “I think the Caira TKA Radar Navigation Program will absolutely adjust the paradigm of navigation and robotics in arthroplasty – supplying a far better alternative for surgeons, hospitals, and ASCs worldwide when also enhancing patient outcomes.”
By supplying a minimally invasive and expense-effective resolution, Caira Surgical’s technologies is a meaningful improvement to support overcome the obstacles that have prevented the broad marketplace adoption of incumbent robotic and navigation systems. At the moment, these sophisticated technologies are only utilised in significantly less than 20% of TKA procedures due to their inherent disadvantages such as the costly capital gear and per-surgery disposables, complicated workflows and elevated process occasions, further incisions and invasive surgical hardware that can enhance post-operative discomfort and complications.
“The Caira TKA Radar Navigation Program addresses each and every of these shortcomings to actually revolutionize orthopedic surgery,” stated Caira Surgical Chief Executive Officer Jon Greenwald. “It was created to address the frustrations we’ve been hearing from surgeons, hospitals and ASCs because surgical navigation and robotic technologies have been initial introduced in the 1990s, such as workflow, complexity, invasiveness and expense.”
Caira Surgical is at present raising a $ten million Series A Funding Round. Series A funding will be utilised to drive continued solution improvement and R&D and assistance a restricted industrial release of the Caira TKA Radar Navigation Program in 2024. These attending the Emerging Medtech Summit who are interested in scheduling a a single-on-a single meeting with Caira Surgical senior leadership can do so by emailing email@example.com.
LSI USA ’23 is the sector-top medtech investment and partnering occasion featuring additional than 250 innovators presenting to additional than 1,000 major investors and strategics. The occasion will take spot March 20 – 23, 2023 at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, Calif. Caira Surgical will present as aspect of Track 1 on Wednesday, March 22 from 11:30 – 11:39 a.m. PT. For additional information and facts, take a look at https://www.lifesciencemarketresearch.com/medtech-summit-2023.
About Caira Surgical
Caira is revolutionizing the usability, economics, security, and accessibility of sophisticated surgical navigation and robotics for orthopedic surgery. The company’s initial solution is a navigation technique for total knee replacement. Employing Caira’s sophisticated, proprietary sub-millimeter correct Radar Surgical Tracking technologies, Caira Surgical Navigation eliminates line-of-sight interference, invasive surgical instruments, and several incisions inherent in current surgical tracking systems. Caira’s technologies enables a straightforward workflow and substantially reduces the expense and complexity of using sophisticated technologies in joint replacement surgery. The organization focuses on developing technologies that overcomes adoption barriers to make sophisticated technologies additional accessible to surgeons, sufferers, hospitals, and ambulatory surgery centers (ASCs) worldwide. For additional information and facts, please take a look at cairasurgical.com.